Literature DB >> 27773862

Possible mechanical causes of scaffold thrombosis: insights from case reports with intracoronary imaging.

Yohei Sotomi1, Pannipa Suwannasom, Patrick W Serruys, Yoshinobu Onuma.   

Abstract

The advent of intracoronary stents has greatly increased the safety and applicability of percutaneous coronary interventions. One of the drawbacks of drug-eluting stents (DES) is the increased risk of late and very late stent thrombosis (ST). It was anticipated that the risks of ST after DES implantation would be solved with the advent of fully biodegradable scaffolds, which offer the possibility of transient scaffolding of the vessel to prevent acute vessel closure and recoil while also transiently eluting an antiproliferative drug to counteract constrictive remodelling and excessive neointimal hyperplasia. In spite of the enthusiasm for the concept of bioresorbable scaffolds, current clinical data on the Absorb bioresorbable vascular scaffold (BVS) have generated concerns about scaffold thrombosis (ScT) in both the early and late phases. However, the causes of ScT in both the early and late phases have yet to be fully elucidated. This article seeks to provide insights into the possible mechanical causes of ScT in the early and late phases with data stemming from intracoronary imaging (intravascular ultrasound and optical coherence tomography) of the currently published ScT cases following the implantation of BVS and reviews the practical recommendations for implantation of the BVS made by a group of experts.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 27773862     DOI: 10.4244/EIJ-D-16-00471

Source DB:  PubMed          Journal:  EuroIntervention        ISSN: 1774-024X            Impact factor:   6.534


  18 in total

1.  Different behaviors of bioresorbable vascular scaffold in different types of calcified lesion: Insights from intravascular imaging.

Authors:  Satoru Mitomo; Akihito Tanaka; Luciano Candilio; Lorenzo Azzalini; Mauro Carlino; Azeem Latib; Antonio Colombo
Journal:  J Cardiol Cases       Date:  2018-01-02

Review 2.  A Practical Approach to Assessing Stent Results with IVUS or OCT.

Authors:  Daisuke Hachinohe; Satoru Mitomo; Luciano Candilio; Azeem Latib
Journal:  Methodist Debakey Cardiovasc J       Date:  2018 Jan-Mar

Review 3.  Bioresorbable Coronary Scaffolds: Deployment Tips and Tricks and the Future of the Technology.

Authors:  J Ribamar Costa; Alexandre Abizaid
Journal:  Methodist Debakey Cardiovasc J       Date:  2018 Jan-Mar

Review 4.  Bioresorbable Scaffolds for Coronary Stenosis: When and How Based Upon Current Studies.

Authors:  Alexandre Abizaid; J Ribamar Costa
Journal:  Curr Cardiol Rep       Date:  2017-03       Impact factor: 2.931

Review 5.  Magmaris: a new generation metallic sirolimus-eluting fully bioresorbable scaffold: present status and future perspectives.

Authors:  Claudio Rapetto; Massimo Leoncini
Journal:  J Thorac Dis       Date:  2017-08       Impact factor: 2.895

6.  Strain-induced accelerated asymmetric spatial degradation of polymeric vascular scaffolds.

Authors:  Pei-Jiang Wang; Nicola Ferralis; Claire Conway; Jeffrey C Grossman; Elazer R Edelman
Journal:  Proc Natl Acad Sci U S A       Date:  2018-02-26       Impact factor: 11.205

7.  Effect of working environment and procedural strategies on mechanical performance of bioresorbable vascular scaffolds.

Authors:  Pei-Jiang Wang; Farhad Rikhtegar Nezami; Maysam B Gorji; Francesca Berti; Lorenza Petrini; Tomasz Wierzbicki; Francesco Migliavacca; Elazer R Edelman
Journal:  Acta Biomater       Date:  2018-10-17       Impact factor: 8.947

8.  Mid-term and long-term safety and efficacy of bioresorbable vascular scaffolds versus metallic everolimus-eluting stents in coronary artery disease: A weighted meta-analysis of seven randomised controlled trials including 5577 patients.

Authors:  J Elias; I M van Dongen; R P Kraak; R Y G Tijssen; B E P M Claessen; J G P Tijssen; R J de Winter; J J Piek; J J Wykrzykowska; J P S Henriques
Journal:  Neth Heart J       Date:  2017-07       Impact factor: 2.380

9.  Everolimus-eluting bioresorbable vascular scaffold in daily clinical practice: A single-centre experience.

Authors:  W S Remkes; R S Hermanides; M W Kennedy; E Fabris; E Kaplan; J P Ottervanger; A W J van 't Hof; E Kedhi
Journal:  Neth Heart J       Date:  2017-11       Impact factor: 2.380

Review 10.  Impact of PSP Technique on Clinical Outcomes Following Bioresorbable Scaffolds Implantation.

Authors:  Luis Ortega-Paz; Salvatore Brugaletta; Manel Sabaté
Journal:  J Clin Med       Date:  2018-02-06       Impact factor: 4.241

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.